Effects of ticagrelor in a mouse model of ischemic stroke
Sign Up to like & getrecommendations! Published in 2017 at "Scientific Reports"
DOI: 10.1038/s41598-017-12205-w
Abstract: Ticagrelor is a direct acting and reversibly binding P2Y12 antagonist approved for the prevention of thromboembolic events. Its potential benefits in ischemic stroke have not been investigated sufficiently. Mice were subjected to 2 hours of transient… read more here.
Keywords: ischemic stroke; ticagrelor; effects ticagrelor; mouse model ... See more keywords